Luteinising hormone releasing hormone agonist in women with endometriosis.
letter
OA: green
CC0
⤵ 6 in-corpus citations
AI-generated summary
This study investigated the efficacy of luteinizing hormone-releasing hormone agonists for treating women diagnosed with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (4)
- Antigonadotropin (danazol) in the treatment of endometriosis via openalex
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS. via openalex
- W1999683827 via openalex
- W2395322658 via openalex
Cited by (6)
- Comparison of Buserelin to Danazol Therapy in Endometriosis 1990
- Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study 1990
- Comparison of Buserelin to Danazol Therapy in Endometriosis 1990
- Buserelin 1990
- GnRH Analogues in the Treatment of Endometriosis 1989
- Treatment of Endometriosis by Nasal Administration of Nafarelin 1987
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:09:55.985569+00:00
License: CC0
· commercial use OK